Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

ANI Pharmaceuticals, Inc.

http://www.anipharmaceuticals.com/

Latest From ANI Pharmaceuticals, Inc.

Two New Biotechs Spin Out From Edinburgh’s Regenerative Medicine Centre

Scotland’s investment in regenerative medicine is paying off with two promising start-ups, one targeting liver disease, the other oncology, launching within days of each other.

Gene Therapy Regenerative Medicine

Finance Watch: $320m In New VC Deals Includes $110m Round For Neogene

Private Company Edition: Neogene, Escient, ESCAPE, Resolution and Attralus raised a combined $320m in venture capital rounds. Also, large Recursion round could double the size of its pipeline, Korro Bio raised $91.5m and Flagship launched Generate Biomedicines.

Financing Innovation

As Other US Agencies Respond To The Pandemic, FEMA Fine-Tunes Plan Of Action

Industry wonders how emergency agency's COVID-19 public-private partnerships will fit in with the others.

Coronavirus COVID-19 Manufacturing

Bayer Back In M&A Mode To Boost Pipeline

The head of the German group's pharma BD team tells Scrip that Bayer has created a system which allows it to move quickly when sealing partnerships, as seen with the KaNDy buy on 11 August.

Deals Leadership
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Services
  • Pharmaceuticals
    • Generic Drugs
  • Other Names / Subsidiaries
    • BioSante Pharmaceuticals, Inc.
    • Cell Genesys, Inc.
UsernamePublicRestriction

Register